PT/INR normal range (and the warfarin target)

A normal PT is 11 to 14 seconds and a normal INR is 0.9 to 1.2 in the Open RN Health Alterations table the MagstoneRN app uses. On warfarin, the drug label's target INR is 2.0 to 3.0 for DVT, PE or non-valvular atrial fibrillation, and 2.5 to 3.5 with some mechanical heart valves. Ranges differ between labs.[1][2][3]

Start monthly 5-day trial

Payment method required. First-time subscribers only. After the trial, the plan costs $19.99/month until you cancel. You aren't charged if you cancel before the trial ends. Cancel anytime online.

Quick facts

PT, INR, and aPTT values, with the warfarin and heparin targets from the drug labels
TestRangeUnitApplies to
PT (prothrombin time)[1]11-14secondsTeaching table, population not stated
INR[1]0.9-1.2No unitTeaching table, population not stated
INR target on warfarin, DVT, PE or non-valvular atrial fibrillation[2]2.0-3.0No unitDVT, PE or non-valvular atrial fibrillation
INR target on warfarin, mechanical mitral valve (tilting disk or bileaflet), or caged ball or caged disk valve[2]2.5-3.5No unitMechanical mitral valve (tilting disk or bileaflet), or caged ball or caged disk valve
aPTT (heparin's lab, for comparison)[1]20-40secondsTeaching table, population not stated
aPTT target on heparin[4]1.5-2times normalFull-dose heparin

On warfarin, a high INR raises bleeding risk and a low one raises clot risk

  • The warfarin label says an INR above 4.0 appears to add no benefit for most patients and is linked to a higher risk of bleeding.[2]
  • Bleeding signs to assess and teach include gums that bleed after brushing, nosebleeds, unusual bruising, dark brown or red urine, red or black tarry stools, heavier menstrual flow, headache, dizziness and weakness.[2]
  • A low INR can mean the blood clots too easily, with a risk of dangerous clots.[5]

INR is checked daily when warfarin starts, then every 1 to 4 weeks

  • The label calls for an INR every day after the first dose until results settle in the target range, then every 1 to 4 weeks once stable.[2]
  • Check the INR more often when the patient starts or stops another drug or an herbal product, or when another drug's dose changes.[2]

Steady vitamin K intake keeps the INR steady

  • Teach a normal, balanced diet with a consistent amount of vitamin K and no drastic diet changes, like suddenly eating far more leafy greens.[2]

Warfarin bleeding risk and INR monitoring are in the Antiplatelet and anticoagulant reasoning flashcard deck. Find the deck in the free app preview.

Open the free app preview

How it shows up on nursing exams

  • Match the drug to the lab. Warfarin is monitored with PT/INR. Heparin is monitored with aPTT, and its label considers the dose adequate at an aPTT of 1.5 to 2 times normal.[2][4][5]
  • PT results vary with the lab and the test method, so they are converted to an INR, which can be compared across labs.[5]
  • If the patient is not taking warfarin, a high PT/INR can point to liver disease, vitamin K deficiency or a bleeding disorder.[5]

Practice question

A 71-year-old patient with non-valvular atrial fibrillation takes warfarin at home. The patient's target INR is 2.0 to 3.0. Today the INR is 4.6, and the patient reports that the gums bled after brushing this morning. Blood pressure is 134/82 mm Hg and heart rate 78/min and irregular. The evening warfarin dose is due. Which action should the nurse take first?

  1. A. Give the warfarin dose, then recheck the INR tomorrow
  2. B. Report the INR and bleeding gums before the dose
  3. C. Give vitamin K to bring the INR back into range
  4. D. Teach the patient to eat more green leafy vegetables
Show the answer and why

Correct answer: B. Report the INR and bleeding gums before the dose

  • A. Incorrect. An INR of 4.6 is above the 2.0 to 3.0 target. The label says an INR above 4.0 appears to add no benefit for most patients and is linked to a higher bleeding risk, and the gums are already bleeding.
  • B. Correct. The INR is above target, and gums that bleed after brushing are one of the bleeding signs the label tells patients to report. The provider adjusts warfarin based on the INR, so both findings go to the provider before the dose.
  • C. Incorrect. Vitamin K can reverse warfarin, but the label bases that treatment on the INR level, any bleeding and the clinical situation. The provider decides after hearing the findings, so the report comes first.
  • D. Incorrect. More vitamin K in food can lower the INR, but the label advises a consistent vitamin K intake and warns against drastic diet changes, like suddenly eating far more leafy greens. A diet swing is not how a high INR is managed.

Sources for this question: [2][5]

Memory hook: Warfarin watches the INR; heparin watches the aPTT.

Questions about PT and INR

What is a normal INR?

It is 0.9 to 1.2 in the Open RN Health Alterations table, which the MagstoneRN app uses. On warfarin, the drug label's target is 2.0 to 3.0 for DVT, PE or non-valvular atrial fibrillation, and 2.5 to 3.5 with some mechanical heart valves.[1][2]

What INR is too high on warfarin?

An INR above the patient's target can mean a risk of dangerous bleeding. The warfarin label adds that an INR above 4.0 appears to give no extra benefit for most patients and is linked to a higher bleeding risk.[2][5]

Is PT/INR or aPTT used for heparin?

aPTT. PT/INR tracks warfarin. The heparin label considers the dose adequate at an aPTT of 1.5 to 2 times normal.[2][4]

Study this topic in MagstoneRN

Study the Antiplatelet and anticoagulant reasoning deck with spaced review, and look up PT, INR, and aPTT in the Lab values tool.

Browse flashcards
Start monthly 5-day trial

Payment method required. First-time subscribers only. After the trial, the plan costs $19.99/month until you cancel. You aren't charged if you cancel before the trial ends. Cancel anytime online.

MagstoneRN plans and trial terms

Sources for this page

  1. Health Alterations, Appendix A: Normal Reference Ranges (opens in a new tab). Open RN, Chippewa Valley Technical College (2024). License: CC BY 4.0. Accessed October 18, 2026.
  2. Jantoven (warfarin sodium) tablets, prescribing information (DailyMed version 13, July 8, 2025) (opens in a new tab). Upsher-Smith Laboratories, on DailyMed (National Library of Medicine). License: U.S. drug label published on DailyMed; facts cited, no text reused. Accessed October 18, 2026.
  3. How to Understand Your Lab Results (updated September 4, 2025) (opens in a new tab). MedlinePlus, National Library of Medicine. License: Public domain (U.S. government work). Accessed October 18, 2026.
  4. Heparin sodium injection, prescribing information (DailyMed version 8, August 15, 2025) (opens in a new tab). Fresenius Kabi USA, on DailyMed (National Library of Medicine). License: U.S. drug label published on DailyMed; facts cited, no text reused. Accessed October 18, 2026.
  5. Prothrombin Time Test and INR (PT/INR) (updated May 15, 2024) (opens in a new tab). MedlinePlus, National Library of Medicine. License: Public domain (U.S. government work). Accessed October 18, 2026.

A number in brackets links to the source for the fact it follows.

Report a wrong or outdated fact through support and MagstoneRN will correct the page.

Sources: 5 entries, last accessed October 18, 2026.